Literature DB >> 2001249

Prostaglandins E2 and F2 alpha increase fructose 2,6-bisphosphate levels in isolated hepatocytes.

A M Gómez-Foix1, J E Rodríguez-Gil, J J Guinovart, F Bosch.   

Abstract

In hepatocytes isolated from fed rats, prostaglandin E2 (PGE2) and prostaglandin F2 alpha (PGF2 alpha) increased, in a time- and dose-dependent manner, fructose 2,6-bisphosphate [Fru(2,6)P2] levels and stimulated the glycolytic flux. The rise in Fru(2,6)P2 was related to an increase in glucose 6-phosphate levels which resulted from the stimulation of glycogenolysis. In cells obtained from 24 h-starved rats, no effects of either PGE2 or PGF2 alpha could be observed. In addition, when the stimulation of glycogenolysis was abolished by incubation of fed-rat hepatocytes in a Ca2(+)-depleted medium, Fru(2,6)P2 levels did not increase. Furthermore, no effects of PGs on 6-phosphofructo-2-kinase activity could be observed. These results indicate that PGE2 and PGF2 alpha show similar actions to Ca2(+)-dependent hormones on hepatic glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2001249      PMCID: PMC1149955          DOI: 10.1042/bj2740309

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  17 in total

1.  Conditioned media of Kupffer and endothelial liver cells influence protein phosphorylation in parenchymal liver cells. Involvement of prostaglandins.

Authors:  E Casteleijn; J Kuiper; H C Van Rooij; J F Koster; T J Van Berkel
Journal:  Biochem J       Date:  1988-06-01       Impact factor: 3.857

2.  Effect of prostaglandin E 1 administration on the liver glycogen synthetase and phosphorylase systems.

Authors:  R T Curnow; F Q Nuttall
Journal:  J Biol Chem       Date:  1972-03-25       Impact factor: 5.157

Review 3.  Mechanisms of hormonal regulation of hepatic glucose metabolism.

Authors:  J H Exton
Journal:  Diabetes Metab Rev       Date:  1987-01

4.  Prostaglandins E2 and F2 alpha affect glycogen synthase and phosphorylase in isolated hepatocytes.

Authors:  A M Gómez-Foix; J E Rodriguez-Gil; J J Guinovart; F Bosch
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

5.  Direct activation by prostaglandin F2 alpha but not thromboxane A2 of glycogenolysis via an increase in inositol 1,4,5-trisphosphate in rat hepatocytes.

Authors:  A Athari; K Jungermann
Journal:  Biochem Biophys Res Commun       Date:  1989-09-29       Impact factor: 3.575

6.  Prostaglandin D2 mediates the stimulation of glycogenolysis in the liver by phorbol ester.

Authors:  E Casteleijn; J Kuiper; H C Van Rooij; J A Kamps; J F Koster; T J Van Berkel
Journal:  Biochem J       Date:  1988-02-15       Impact factor: 3.857

7.  Hormonal control of glycogenolysis in parenchymal liver cells by Kupffer and endothelial liver cells.

Authors:  E Casteleijn; J Kuiper; H C van Rooij; J A Kamps; J F Koster; T J van Berkel
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

8.  The induction of glycogenolysis in the perfused liver by platelet activating factor is mediated by prostaglandin D2 from Kupffer cells.

Authors:  J Kuiper; Y B De Rijke; F J Zijlstra; M P Van Waas; T J Van Berkel
Journal:  Biochem Biophys Res Commun       Date:  1988-12-30       Impact factor: 3.575

9.  Prostaglandin F2 alpha and the thromboxane A2 analogue ONO-11113 stimulate Ca2+ fluxes and other physiological responses in rat liver. Further evidence that prostanoids may be involved in the action of arachidonic acid and platelet-activating factor.

Authors:  J G Altin; F L Bygrave
Journal:  Biochem J       Date:  1988-02-01       Impact factor: 3.857

10.  Stimulation of hepatic glycogenolysis by 12-O-tetradecanoyl-phorbol-13-acetate (TPA) via cyclooxygenase products.

Authors:  J A García-Sáinz; S M Hernández-Sotomayor
Journal:  Biochem Biophys Res Commun       Date:  1985-10-15       Impact factor: 3.575

View more
  1 in total

Review 1.  Liver cytoprotection by prostaglandins.

Authors:  J Quiroga; J Prieto
Journal:  Pharmacol Ther       Date:  1993       Impact factor: 12.310

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.